Edward W. Sparrow Hospital

Lansing, Michigan 48912

0 studies enrolling now · 2 studies all time

What they study most

Idiopathic Multicentric Castleman's Disease, Metastatic Prostate Cancer

Studies at this site

• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed
• Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease — Stopped early